An analysis of subclass showed that SIRT7 was higher expressed in different subclasses than that in normal breast tissues (normal vs. breast cancer-luminal, p < 10−12; normal vs. HER2-positive breast cancer, p < 10−6; normal vs. TNBC, p < 10−12). Here, SIRT7 is linked to breast carcinoma.